PL1664087T3 - Izolacja prionów z zastosowaniem cząstek tlenków metali - Google Patents

Izolacja prionów z zastosowaniem cząstek tlenków metali

Info

Publication number
PL1664087T3
PL1664087T3 PL04783316T PL04783316T PL1664087T3 PL 1664087 T3 PL1664087 T3 PL 1664087T3 PL 04783316 T PL04783316 T PL 04783316T PL 04783316 T PL04783316 T PL 04783316T PL 1664087 T3 PL1664087 T3 PL 1664087T3
Authority
PL
Poland
Prior art keywords
biological material
metal oxides
particulate metal
metal oxide
silicon dioxide
Prior art date
Application number
PL04783316T
Other languages
English (en)
Inventor
Christopher J Stenland
Jarrett C Terry
Jeffrey A Yuziuk
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of PL1664087T3 publication Critical patent/PL1664087T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Silicon Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04783316T 2003-09-10 2004-09-07 Izolacja prionów z zastosowaniem cząstek tlenków metali PL1664087T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/659,789 US20050054003A1 (en) 2003-09-10 2003-09-10 Prion clearance using particulate metal oxides
PCT/US2004/029024 WO2005026197A1 (en) 2003-09-10 2004-09-07 Prion clearance using particulate metal oxides
EP04783316A EP1664087B1 (en) 2003-09-10 2004-09-07 Prion clearance using particulate metal oxides

Publications (1)

Publication Number Publication Date
PL1664087T3 true PL1664087T3 (pl) 2008-06-30

Family

ID=34227009

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04783316T PL1664087T3 (pl) 2003-09-10 2004-09-07 Izolacja prionów z zastosowaniem cząstek tlenków metali

Country Status (13)

Country Link
US (1) US20050054003A1 (pl)
EP (1) EP1664087B1 (pl)
JP (1) JP2007527405A (pl)
AT (1) ATE370962T1 (pl)
AU (1) AU2004272591A1 (pl)
CA (1) CA2538288A1 (pl)
CY (1) CY1107791T1 (pl)
DE (1) DE602004008488T2 (pl)
DK (1) DK1664087T3 (pl)
ES (1) ES2291947T3 (pl)
PL (1) PL1664087T3 (pl)
PT (1) PT1664087E (pl)
WO (1) WO2005026197A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4769925B2 (ja) * 2006-03-15 2011-09-07 国立大学法人東北大学 異常型プリオン蛋白質の濃縮方法、および除去方法
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
TW201808312A (zh) * 2016-05-09 2018-03-16 理研技術系統股份有限公司 減低異常型普立昂蛋白之感染力的方法及預防治療普立昂疾病用之醫藥組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
IL89123A (en) * 1989-01-31 1993-08-18 Ilana Tamir Method for determination of ldl-cholesterol
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5290703A (en) * 1992-12-14 1994-03-01 Miles, Inc. Method for the separation of high density lipoprotein from blood samples
EP0920630B1 (en) * 1996-05-29 2002-07-31 McGILL UNIVERSITY Prion binding proteins and uses thereof
US5808011A (en) * 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
WO2001000235A1 (en) * 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
WO2002063306A2 (en) * 2001-01-16 2002-08-15 Biotransplant, Inc. Use of high density microparticles for removal of pathogens
US6743899B2 (en) * 2001-05-08 2004-06-01 Serologicals Royalty Company Process for inactivating prions in lipoproteins
DE60211339D1 (de) * 2001-06-22 2006-06-14 Argonide Corp Submikron filter
AU2004227389B2 (en) * 2003-04-04 2010-09-16 North Carolina State University Prion protein binding materials and methods of use

Also Published As

Publication number Publication date
CA2538288A1 (en) 2005-03-24
DK1664087T3 (da) 2007-12-27
DE602004008488D1 (de) 2007-10-04
EP1664087A1 (en) 2006-06-07
AU2004272591A1 (en) 2005-03-24
JP2007527405A (ja) 2007-09-27
DE602004008488T2 (de) 2008-01-03
US20050054003A1 (en) 2005-03-10
EP1664087B1 (en) 2007-08-22
ATE370962T1 (de) 2007-09-15
CY1107791T1 (el) 2013-06-19
PT1664087E (pt) 2007-11-09
WO2005026197A1 (en) 2005-03-24
ES2291947T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
SG150550A1 (en) Pharmaceutical preparation containing an antibody for the egf receptor
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
WO2003105252A3 (en) CERAMIC ANODES AND PROCESS FOR PRODUCING THE SAME
MY150549A (en) Process for concentration of antibodies and therapeutic products thereof
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
HK1064120A1 (en) Hybrid expression of neisserial proteins
AU2002310321A8 (en) Compositions and methods for high-level, large-scale production of recombinant proteins
IL160319A0 (en) Compositions and method of treating diabetes
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
DE60207894D1 (en) 4-(piperidyl- und pyrrolidyl-alkyl-ureido)-chinoline als urotensin ii rezeptor antagonisten
GB0216001D0 (en) Process and composition
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL157335A0 (en) Lentiviral packaging constructs
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
GB0216002D0 (en) Process and composition
WO2001098245A3 (en) Triphenyl compounds as interleukin-4 antagonists
PL1664087T3 (pl) Izolacja prionów z zastosowaniem cząstek tlenków metali
GB0324656D0 (en) A protein involved in ovarian cancer
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
MXPA02012015A (es) Ligandos de receptores para integrinas.
IL156640A (en) Process for preparing arylethanoldiamines from imidazooxazoles, starting material and intermediate used in the process
GB0409559D0 (en) Polypeptide
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies